Why the study?
High-risk perioperative PE treatment is challenging because systemic thrombolysis carries high bleeding risks and open embolectomy has high mortality, leaving catheter-directed ultrasound-accelerated thrombolysis as a potential alternative.
Does ultrasound-accelerated catheter-directed thrombolysis improve outcomes in patients with high-risk perioperative pulmonary embolism?
Does ultrasound-accelerated catheter-directed thrombolysis improve outcomes in patients with high-risk perioperative pulmonary embolism?
Ultrasound-accelerated catheter-directed thrombolysis may be a feasible and effective treatment option for high-risk perioperative pulmonary embolism requiring VA-ECMO, though bleeding risks remain significant.
May support feasibility of ultrasound-accelerated thrombolysis in high-risk perioperative PE on VA-ECMO; hypothesis-generating and requires prospective confirmation.
Background: Treatment of high-risk pulmonary embolism (PE) in perioperative patients remains challenging. Systemic thrombolysis is associated with a high risk of major bleedings and intracranial haemorrhage. High mortality rates are reported for open pulmonary embolectomy. Therefore, postoperative surgical patients may benefit substantially from catheter-directed ultrasound-accelerated thrombolysis (USAT). Case summary: We report two cases of high-risk perioperative PE. Both patients developed severe haemodynamic instability leading to cardiac arrest. After the implantation of a veno-arterial extracorporeal membrane oxygenation (ECMO), they were both successfully treated with USAT. Adequate improvement of right ventricular function was achieved; thus, ECMO could be successfully weaned after three and four days, respectively. Both patients showed favourable outcomes and could be discharged to rehabilitation. Discussion: The current European guideline on treatment of PE offers no specific therapies for perioperative patients with high-risk PE. However, systemic thrombolysis is often excluded due to the perioperative setting and the risk of major bleeding. Catheter-directed thrombolysis was shown to utilise less thrombolytic agent while obtaining comparable thrombolytic effects. The risk for major bleeding (including intracranial haemorrhage) is also significantly lowered. Conclusion: Further prospective randomised controlled trials are necessary to determine the value of USAT treatment of high-risk PE in perioperative patients.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: